That's important, since the way a protein in the human body folds identifies if a pharmaceutical will be able to bind to that protein and work. Simply put, we have to know how these proteins fold if we want a drug to work. Historically, this has actually been a trial-and-error process (melania trump). And now, Alpha, Fold can anticipate protein folding with 92. 4% accuracy. That's going to make it a lot easier to produce drugs that do what they're developed to do. This was a development almost nobody observed. However it's going to have extensive ramifications for curing disease. I anticipate that Alpha, Fold will be 98% precise by the end of 2021.
And, obviously, there will be lots of investment chances in this space, too. Moving subjects It's going to be a good year for bitcoin. I'm bullish on it in 2021 (brownstone research). That stated, I still think bitcoin will continue to be unstable. We're close to all-time highs. I wouldn't be surprised if it pulled back perhaps significantly prior to going greater - jeff brown tech stock 2021. I've been covering bitcoin for a very long time now. One of the first research reports I ever released was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that initial suggestion, I entitled my report "What's the Big Offer With Bitcoin?" That shows you where the discussion was at the time. We were primarily educating readers. However that's not the huge question anymore. Now we're seeing institutional cash lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, specific niche enterprise. Mass, Mutual is a trusted 170-year-old institution. So think of that. In 5 years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
Which's a big factor I'm bullish on it this year. jeff bezos. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus forecast 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than 20 years. These companies raised a total of $172 billion. That's an all-time high beating the previous annual record by 43%. I predict 2021 will be another record year in IPOs. There are many excellent private companies on the brink of striking the general public markets And I have actually been working on a new method for you to invest even before these companies go public.
This opportunity has been developing over the last couple of years. I can't wait to inform you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to learn all the information. Go right here to reserve your spot free of charge.
Emma Walsh here, handling editor of the Diary. Routine Journal readers know that tech isn't our usual beat (self-driving cars). And when it concerns tech investing, we leave it to the professionals. Thankfully, we have numerous such experts in our Rolodex. Our colleague Jeff Brown will recognize to our long time readers. He is among the most accomplished tech investing professionals we understand (brownstone research). In reality, he had several triple-digit returns in his Brownstone Research portfolios last year. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to have a look at the huge image and anticipate what's simply around the corner.
That consists of things like 5G networks, biotech, synthetic intelligence, and a lot more. These patterns are experiencing exponential development and producing extraordinary opportunities for financiers. I wish to make sure all our readers are gotten ready for what's next. And with that in mind, let me draw the photo of what I see coming in the next 12 months Our new 5G (fifth-generation) wireless networks are a topic I've been covering for years now. toxic tech 5 tech darlings. However regardless of what many readers might believe, this is a pattern that's just getting started. Although the COVID-19 pandemic disrupted supply chains last year, an impressive 250 million 5G-enabled gadgets were still offered.
And all of this eventually led to Apple delaying the release of the 5G-enabled i, Phone 12 by 2 months (jeff brown 1 biotech). Losing two months of manufacturing and sales really impacts the number of 5G gadgets are sold in the fiscal year. When you think about all of that, selling 250 million systems is amazing. More significantly, the hold-ups triggered by the pandemic produced a lots of suppressed need. And that need is now going to be pushed into 2021. In reality, I anticipate that more than 500 million 5G devices will be delivered in 2021 - brownstone research stock. And that's not my only 5G forecast When I have actually spoken about 5G in the past, I have actually described its three various stages.
In Stage Two, 5G devices go on sale. 5G phones and other items begin to reach consumers. And in Phase 3, 5G services start to be offered (jeff brown investor prediction). That's when we start to see applications running on 5G networks. Think of things like huge multiplayer video games over a cellphone. That's not possible with 4G. It will be with 5G. And my 2nd 5G prediction for 2021 is that we will begin Stage Three by this summer. This begins something of a virtuous cycle: The majority of people do not truly care about the innovation. However they will care if there are amazing applications that can only be accessed with a 5G phone.
That results in more 5G apps being developed. In truth, 5G is going to open up a suite of amazing applications: self-driving automobiles, the Internet of Things, robotic surgical treatment, and more. All of these innovations need 5G. The financial investment opportunities going forward will be huge. Stepping far from 5G, the next essential technology I anticipate in 2021 is CRISPR genetic editing. CRISPR represents "clustered regularly interspaced brief palindromic repeat." It's a mouthful. However it is among the most exciting advancements in biotechnology. At a high level, CRISPR is a technology that can modify our genetic makeup as if it were software.
The program can crash or not work correctly. CRISPR uses a comparable idea however with our genetic code. "Typos" in our genome can lead to disease. CRISPR can correct these "typos." For years, CRISPR was mainly a niche innovation that wasn't well comprehended. And throughout that time, there were really just 3 companies operating in this space. However things are altering. CRISPR is no longer just theoretical. We're seeing real outcomes. We're treating illness and seeing that this innovation just works. And as a result, a "second crop" of early-stage CRISPR companies is going public and delivering unbelievable returns. This entire market is successfully a greenfield chance.
There's space for lots of companies to exist in this space. exponential growth. And there will be more. That's my forecast for CRISPR in 2021. I forecast that 2 or three more hereditary modifying companies will hold their IPOs. Sticking to biotechnology, we are seeing amazing things happening at the merging of biotech and synthetic intelligence (AI). Google's AI subsidiary, Deep, Mind, just announced at the end of 2020 that its most current Alpha, Fold software application can properly anticipate the folding of a protein based entirely on its amino acid sequence with 92. 4% precision. That's important because the method a protein in the body folds figures out if a pharmaceutical will have the ability to bind to that protein and be reliable.
Historically, this has actually been a trial-and-error procedure. Now, Alpha, Fold can anticipate protein folding with 92. 4% precision. That's going to make it a lot easier to create drugs that do what they're designed to do. And here's my next prediction. I anticipate that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not just one however a number of drug therapies produced utilizing this technology. This was one of those breakthroughs that almost nobody saw. However it's going to have profound implications for treating disease. And, of course, there will be lots of financial investment chances in this area, too.
It's going to be an excellent year for bitcoin. I'm bullish on it in 2021. That said, I still believe bitcoin will continue to be volatile. We're close to all-time highs. I would not be amazed if it pulled back perhaps significantly prior to going greater. I've been covering bitcoin for a long time now. Among the first research reports I ever released was on bitcoin - jeff brown prediction. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anyone who followed my suggestion. However at the time of that preliminary recommendation, I entitled my report, "What's the Big Deal With Bitcoin?" That shows you where the discussion was at the time.
However nobody is asking that concern any longer. Now, we're seeing institutional money lastly taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, specific niche enterprise. jeff brown genetic sequencing stock. Mass, Mutual is a 150-year-old institution. So think of that. In five years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a huge factor why I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more bonus offer forecast In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown deserves about $27. 5 million and claims the information depends on date as of February 2021, but we might not separately confirm this claim. Given Jeff Brown's past, he likely has a considerable net worth, but we can't hammer down an exact figure at this minute. Brown is best understood for his sage-like ability to select winning technology stocks. He invested more than 25 years investigating innovation business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's substantial experience provides him an excellent viewpoint on the marketplace. He's constantly on the hunt for brand-new opportunities, and he shares a lot of his best picks in the Future Report.
That's full marks, however it's not absurdly reasoned. Brown has an excellent credibility as a stock-picker, and he effectively anticipated some of the greatest financial occasions of the past twenty years. Although he doesn't appear to release his choices to the general public, the service's success is a direct sign of Brown's stock-picking expertise. Nobody on Wall Street gets it right every time, but Jeff Brown's precise predictions have made him legions of dedicated followers. That states a lot about his capability. The Future Report is released by Brownstone Research, a prominent monetary research study publisher. Brownstone Research study uses numerous research study services with a wide array of specializations - jeff brown market predictions.
The business is likewise affiliated with Bonner & Partners, another well-respected research study publisher - biotech stock. On its website, Brownstone says its objective is to offer retail financiers with professional-grade research study: "For too long, the finest investment research study has not been available to specific investors. It has been generally scheduled for financial investment banks, hedge funds, personal equity, and high-net-worth customers. jeff brown biotech genome sequencing. The objective of Brownstone Research is to make that type of exclusive research study offered to any investors seeking to get an edge in the markets. The goal is easy to deliver distinct and lucrative investment research discovered nowhere else." -Brownstone Research study website excerpt from the Jeff Brown is the creator of Brownstone Research, and he also acts as the company's Chief Financial investment Analyst.
With Brown directing the ship, Brownstone Research is a powerhouse publisher with lots to use its customers. After years of consistent success at the helm of top-tier business like Tesla and Space, X, Elon Musk is a home name throughout most of America. If you know even a little bit about the market, you know that he has a track record as a King Midas of sorts. exponential growth. Everything he touches turns to gold! Jeff is well conscious of Elon Musk's executive prowess, so he constantly has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next big task.
In truth, Brown thinks S.A.V. exponential growth. could be "the greatest trend of the 2020s, and he's not alone. Take a look at these quotes from other widely known S.A.V. bulls: Elon's next huge act will be weding two innovative technologies: expert system and electrical cars. Musk hopes the mix will help him develop the very first fully-autonomous, self-driving vehicles ever. It's absolutely nothing brief of the automotive market's Holy Grail. As you understand, electrical cars and self-driving vehicle stocks have actually been huge this year, but the Wall Street machine has approved hype without much concrete result. Despite an extreme boost in competition over the past couple of years, Brown still thinks Musk has the finest opportunity of putting everything together.
tech might be the magic string that connects it all together. S.A.V. stands for Shared Autonomous Car, and it might be the future of transportation. Essentially, this innovation would permit you to rent out your vehicle as an autonomous, self-driving taxi when you're not using it. You just get out of the vehicle and press a button on an app that informs the automobile to "sign up with the fleet." Next thing you understand, you're unwinding on your sofa while your cars and truck shuttles ride-sharers around town. Most importantly, you get to keep a large chunk of the revenues. It sounds insane, but it might be closed than you think.